SESSION TITLE: Student/Resident Case Report Poster - Pulmonary Vascular Disease I
SESSION TYPE: Student/Resident Case Report Poster
PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM
INTRODUCTION: Pulmonary hypertension (PH) due to left heart disease, classified as Group 2 PH, is the most common cause of PH, with significant morbidity and mortality. There is no specific treatment for Group 2 PH other than treatment of the underlying condition. This case study evaluates the use of nesiritide, a recombinant B-type natriuretic peptide (BNP) which is no longer indicated for the treatment for acute or chronic decompensated heart failure, as a drug for severe group 2 PH.